Internal Server Error

About Boston Harbor Angels

Boston Harbor Angels, established in 2004, is an angel investment group based in Boston, United States. It primarily focuses on Series A investments in companies in United States. Its portfolio includes 70 firms, spanning the Life Sciences, Enterprise Applications sectors. Its most notable investments include companies like Carbonite, Myomo and Pixability. As of Oct 2026, Boston Harbor Angels has witnessed 18 portfolio exits. Its latest investment was a $13M Seed round in GelMEDIX on Feb 17, 2026, which also saw participation from Safar Partners and HTL Biotechnology.
To date, 51 investors have co-invested in Boston Harbor Angels's portfolio companies, including prominent names like Launchpad Venture Group.
Key Metrics
Founded Year
2004
Location
Portfolio Companies
Stages of Investment
Series A, Seed & 3 more
Locations of Investment

Boston Harbor Angels' List of Top Investments

Boston Harbor Angels has a portfolio of 70 companies. Their most notable investments are in Xeno Biosciences and TikaTok.Their portfolio spans across United States, Canada and Egypt. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Series A, Seed  and 3 more. Here is the list of top investments by Boston Harbor Angels:
Carbonite provides cloud and hybrid business continuity solution to small and medium sized businesses. Its solutions include Carbonite Personal solution which offers cloud backup solutions for one computer, Carbonite Server Backup, a hybrid server backup solution that provides server backup for physical and virtual servers. It also provides monitoring and reporting solutions for the backup software.

Key facts about Carbonite

Provider of a robotic arm for mobility and rehabilitation. It is a medical device company focused on myoelectric prosthetic technology for powered braces (orthotics) that support weakened extremities. This technology helps individuals with neuromuscular conditions such as stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, and ALS.

Key facts about Myomo

Pixability offers a cloud-based video marketing solution for Youtube. It is a video marketing company offering ad performance measurement on Youtube. Its product PixabilityONE, a video advertising software platform that runs campaigns managed by Pixability and is also used by agencies and brands as a self-serve platform. Also offers a Youtube ad buying and video marketing platform for media professionals. Customers include Zipcar, Sharp, Puma, Loreal, Viacom, Gillette, Chanel, Swarovski, and more.

Key facts about Pixability

  • Founded Year: 2008
  • Location: Boston (United States)
  • Stage: Series C
  • Total Funding till date: $28.4M
  • Employee Count: 110 as on Aug 31, 2026
  • Investors: Progress Ventures, PJC and 14 Others
  • Latest Funding Round: Series C, Apr 08, 2015, $*****
  • Highlight: Editors' Pick
Astrocyte Pharmaceuticals is a small drug development company focussed on developing neuroprotection therapies for brain injury, concussions, stroke, and neurodegenerative disorders. It is developing its drugs that can activate astrocyte, a cell of the CNS that has the potential to treat CNS disorders such as brain injury, stroke, Alzheimer’s Disease.

Key facts about Astrocyte Pharmaceuticals

  • Founded Year: 2014
  • Location: Cambridge (United States)
  • Stage: Series B
  • Total Funding till date: $25.4M
  • Employee Count: 12 as on Sep 30, 2026
  • Investors: UT System, Dreavent and 18 Others
  • Latest Funding Round: Series B, Sep 30, 2026, $*****
  • Highlight: Editors' Pick
Provider of cellulose insulation solutions for facilities. It is provided in the form of recycled cardboard. Its features include a proprietary wet separation and infusion process that floats off contaminants, abundant raw material for the production of insulating material, and an all-borate formulation used to make it fire-safe insulation.

Key facts about CleanFiber

Boston Harbor Angels' Investments by Stage

Boston Harbor Angels has made 11 investments in Series A stage with an average round size of $2.38M, 7 investments in Seed stage with an average round size of $3.52M, 2 investments in Angel stage with an average round size of $1.06M, 1 investment in Series B stage with an average round size of $2.46M and 1 investment in Series D stage with an average round size of $4.1M.
Here are Boston Harbor Angels' investments by stage:
Stage of entry
No. of Investments
Series A
11
Seed
7
Angel
2
Series B
1
Series D
1
Breakdown of Boston Harbor Angels' investments by stage of entrySeries A (11)Seed (7)
Note: We have considered here, only first round of investments

Boston Harbor Angels' Investments by Sector

Boston Harbor Angels has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Consumer and EdTech. Notably, it has invested in 52 Tech companies, 40 Enterprise (B2B) companies, 22 Software companies and at least 19 companies focusing on Consumer (B2C).
Here are Boston Harbor Angels' investments by sector:
Sector
No. of Investments
Life Sciences
11
Enterprise Applications
7
High Tech
4
Consumer
3
EdTech
2
Others
10
Breakdown of Boston Harbor Angels' investments by sectorsLife Sciences (11)Enterprise Applic... (7)
Note: We have considered here, only first round of investments

Boston Harbor Angels' Investments by Geography

Boston Harbor Angels has made most investments in United States (21), followed by China where it has made 1 investment.
Here are Boston Harbor Angels' investments by geography:
Country
No. of Investments
United States
21
China
1
Egypt
1
Breakdown of Boston Harbor Angels' investments by countriesUnited States (21)China (1)
Note: We have considered here, only first round of investments

Boston Harbor Angels' recent investments

Boston Harbor Angels has made 1 investments in 2026 so far - GelMEDIX.
Here are the most recent investments by Boston Harbor Angels:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Feb 17, 2026
United States
Seed
9286
Aug 21, 2023
United States
Series A
8397
  [+6]
Jun 03, 2022
United States
Series B
9891
2021
United States
Series A
6753
Jan 27, 2021
United States
Seed
6732

IPOs and Publicly Listed companies in Boston Harbor Angels' Portfolio

3 of Boston Harbor Angels' portfolio companies have become public. Myomo got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2017 at marketcap of $53M and Corbus Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).
Here are Boston Harbor Angels' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 12, 2017
-
-
1686
Nov 17, 2014
-
-
2586
Apr 16, 2010
-
-
2325

Acquired companies in Boston Harbor Angels' Portfolio

15 companies from Boston Harbor Angels' portfolio have been acquired. The most recent acquisition was Plymouth Industrial REIT in Oct 2025 by Makarora for $*****.
Here are Boston Harbor Angels' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Oct 24, 2025
-
-
1176
Feb 13, 2023
Jan 27, 2021
Seed
3596
Feb 02, 2021
-
-
6998
Aug 19, 2020
-
-
6138
Nov 11, 2019
-
-
8625

Co-investors of Boston Harbor Angels

Over the past 19 years, 109 investors have co-invested in Boston Harbor Angels's portfolio companies. This includes funds and angels.

  • Invested before Boston Harbor Angels: HHS, Connecticut Innovations and 12 others have invested in rounds before Boston Harbor Angels. There are 5 companies where HHS has invested before Boston Harbor Angels and 2 companies where Connecticut Innovations has invested before Boston Harbor Angels.
  • Top Co-investors of Boston Harbor Angels: 51 investors entered a company along with Boston Harbor Angels. These include investors like Launchpad Venture Group (9 companies).
  • Invested after Boston Harbor Angels: A total of 44 investors have invested in Boston Harbor Angels's portfolio after their investments. Top Investors include NIH (4 companies) and HHS (3 companies).

Recent News related to Boston Harbor Angels

•
Boston Harbor Angels to Expand to MiamiPR Newswire•Jan 24, 2022•Boston Harbor Angels
•
Ziad Moukheiber Launches EQX an Evergreen Angel FundCitybizlist•Mar 07, 2018•Boston Harbor Angels
•
Founder Update: BIOARRAY Secures Series A Funding | VDCUniversity of Massachusetts Boston•Apr 29, 2015•Bioarray, Connecticut Innovations, Angel Investor Forum, Boston Harbor Angels
View all news related to Boston Harbor Angels

FAQs about Boston Harbor Angels

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford